Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof
US11180521B2 · kind B2 · utility
6Cited by
24References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 29, 2019 |
| Grant date | Nov 23, 2021 |
| Priority date | — |
| Expiry date | Jan 29, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds of Formula (I) and their salts, and compositions comprising such compounds that are useful for increasing the amount of NAD+ in cells. Also disclosed are methods of using the disclosed compounds and compositions for treating, for example, diseases or disorders related to aging or stress, diabetes, obesity, mitochondrial diseases, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.